Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review.

Autor: Shachar SS; Sourasky Medical Center, Oncology Institute, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: Shlomit10@gmail.com., Korzets Y; Sourasky Medical Center, Oncology Institute, Tel Aviv, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: yasmink@tlvmc.gov.il., Shepshelovich D; Columbia University Medical Center, Division of Internal Medicine, New York, NY, USA. Electronic address: shepshelovich@yahoo.com., Zlothover N; The Hebrew University Faculty of Medicine, Jerusalem, Israel. Electronic address: noa.zlothover@mail.huji.ac.il., Amir E; Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: Eitan.Amir@uhn.ca., Tibau A; Department of Oncology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: atibau@santpau.cat., Goldvaser H; The Hebrew University Faculty of Medicine, Jerusalem, Israel; Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: hadar7g@gmail.com.

Publikováno v: Cancer treatment reviews [Cancer Treat Rev] 2024 Jan; Vol. 122, pp. 102666. Date of Electronic Publication: 2023 Dec 01.